MERS-CoV

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic coronavirus. First identified in 2012, MERS-CoV has caused over 2460 infections and a fatality rate of about 35% in humans. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV), MERS-CoV likely originated...

Полное описание

Сохранить в:

Библиографические подробности
Главные авторы:	Du, Lanying, Li, Fang
Формат:	Online
Язык:	английский
Опубликовано:	MDPI - Multidisciplinary Digital Publishing Institute 2021
Предметы:	QH301-705.5 Q1-390 cell–cell fusion hDPP4 n/a therapeutics animal models HCoV-229E Drivers camels rabbits SARS-CoV MERS-CoV MVA vaccine transmission RBD MERS-CoV nucleocapsid protein complement animal model pseudotyped virus combination MERS-coronavirus peptide mouse model spike protein receptor-binding domain prevention and treatment coronaviruses coronavirus spike glycoprotein therapeutic antibodies vaccine platforms mutation severe acute respiratory syndrome coronavirus pathogenesis fusion inhibitor Coronavirus murine CD8+ T cell epitope lipidomics authentic virus correlates of immunity vaccines neutralizing monoclonal antibodies Middle East respiratory syndrome coronavirus small-molecule inhibitor Middle East Respiratory Syndrome Virus DPP4 pyroptosis cross-neutralization inflammation Qatar spike proteins One Health HKU4 nanobodies mechanism of action neutralizing antibody host factors UHPLC–MS thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
Online-ссылка:	43226
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Ваш комментарий будет первым!

MERS-CoV

Схожие документы